You are using an outdated browser. Please upgrade your browser to improve your experience.

Tchem
PKMYT1
Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase

Protein Summary
Description
Acts as a negative regulator of entry into mitosis (G2 to M transition) by phosphorylation of the CDK1 kinase specifically when CDK1 is complexed to cyclins. Mediates phosphorylation of CDK1 predominantly on 'Thr-14'. Also involved in Golgi fragmentation. May be involved in phosphorylation of CDK1 on 'Tyr-15' to a lesser degree, however tyrosine kinase activity is unclear and may be indirect. May be a downstream target of Notch signaling pathway during eye development. This gene encodes a member of the serine/threonine protein kinase family. The encoded protein is a membrane-associated kinase that negatively regulates the G2/M transition of the cell cycle by phosphorylating and inactivating cyclin-dependent kinase 1. The activity of the encoded protein is regulated by polo-like kinase 1. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000262300
  • ENSP00000262300
  • ENSG00000127564
  • ENST00000440027
  • ENSP00000397739
  • ENST00000573944
  • ENSP00000459123
  • ENST00000574385
  • ENSP00000458943
  • ENST00000574730
  • ENSP00000460868

Symbol
  • MYT1
  • MYT1
  • PPP1R126
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
molecular function
0.94
co-expressed gene
0.85
histone modification site profile
0.84
protein domain
0.73
cell type or tissue
0.67


IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 45.15   (req: < 5)
Gene RIFs: 23   (req: <= 3)
Antibodies: 467   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 45.15   (req: >= 5)
Gene RIFs: 23   (req: > 3)
Antibodies: 467   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 11
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligands: 7
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drugs: 2